Uncategorized


January 13, 2025

Capitol Policy Weekly: Jan. 13-17

By Joe Lieber

This week starts a host of hearings on President-elect Trump’s cabinet nominees (see below). The Senate is also expected to pass an immigration bill, the Laken Riley Act (S. 5), which would require the Dept….

Read More >>

January 12, 2025

Diagnostics’ New Supreme Court Risk

By John Leppard

The Supreme Court’s (SCOTUS) decision on Friday to hear oral arguments in Becerra v. Braidwood, presumably in late March / early April, will likely serve as an overhang for screening test manufacturers [EXAS, GH, MYGN,…

Read More >>

January 11, 2025

[HUM, UNH, CVS, ELV, ALHC] CY26 Medicare Advantage Rates: Likely Upswing in the Final

By Beth Steindecker

CMS’s Friday release of the CY26 Advance Notice (AN) for Medicare Advantage (MA) insurers [HUM, UNH, CVS, ELV, ALHC, CLOV, CNC] came in better than our net YoY benchmark expectations with a proposed net increase…

Read More >>

January 10, 2025

Medtronic (MDT): Renal Denervation Coverage Read-Through?

By John Leppard

This morning’s opening of a Medicare National Coverage Determination (NCD) for privately-held Impulse Dynamics’ Optimizer System bolsters our view that coverage for renal denervation (RDN) systems [Medtronic (MDT), Otsuka / ReCor (4578.JT)] is unlikely to…

Read More >>

January 10, 2025

2025 Tax Primer: Extending the Trump Tax Provision et al.

By Joe Lieber

We continue to believe that Congress is likely to pass a massive $5 trillion- plus tax bill that would extend the 2017 Trump tax cuts, known as the Tax Cut and Jobs Act (TCJA). We…

Read More >>

January 8, 2025

Conference Policy Prep Pack: Healthcare Providers & Insurers

By Beth Steindecker

With a handful of healthcare provider and insurance companies headed to San Francisco next week for a key investor conference, below we provide a set of significant policy-related questions we would like to see management teams address…

Read More >>

January 8, 2025

Exact Sciences (EXAS): Cologuard Plus Coverage Questions

By John Leppard

A Jan. 1 update to CMS’s colorectal cancer (CRC) screening guide appears to support our view that Medicare coverage of EXAS’ Cologuard Plus (0464U: $592) and its 16% rate premium over the legacy version (81528:…

Read More >>

January 6, 2025

Conference Policy Prep Pack: Devices, Diagnostics, & Tools

By John Leppard

With medical device, equipment, diagnostics, and life science tools (LST) companies set to descend on San Francisco next week for a key investor conference, below we provide a set of significant policy-related questions for clients…

Read More >>

January 6, 2025

DC Quick Takes: Reconciliation (Tax bill), Immigration (GEO, CXW) and Cabinet Hearings

By Joe Lieber

While most of the action in DC this week will be ceremonial with Congress certifying the election of President Trump and Vice President JD Vance, much of the talk in town will be on the…

Read More >>

January 2, 2025

DC Quick Takes: Speaker’s Vote, the Debt Limit and Healthcare Extenders

By Joe Lieber

We think House Speaker Mike Johnson (R-LA) faces uphill odds on retaining his Speaker’s role. It’s close to a tossup but if Johnson is re-elected, it isn’t likely to be on the first ballot. Keep…

Read More >>